BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 6500367)

  • 21. [Hepatitis B and the delta agent].
    Jilg W; Roggendorf M; Zoulek G; Schlipköter U; Deinhardt F
    Fortschr Med; 1984 Feb; 102(6):119-21. PubMed ID: 6706267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infections with the hepatitis B virus associated delta agent in an isolated West-African community.
    Goudsmit J; van der Waals F; Ponzetto A; Forzani B; Dobbelaar C
    J Trop Med Hyg; 1984 Dec; 87(6):257-62. PubMed ID: 6534990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibodies to non-structural hepatitis C virus antigens: a link with liver disease activity?
    Gessoni G; Manoni F
    Eur J Med; 1992 Sep; 1(5):288-94. PubMed ID: 1285245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell-mediated immune response to liver tissue antigen and hepatitis B surface antigen after infection with hepatitis B virus in humans.
    Tiku ML; Beutner KR; Tiku K; Ogra PL
    J Infect Dis; 1978 Nov; 138(5):587-96. PubMed ID: 712116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The delta agent: HBsAg particles with delta antigen and RNA in the serum of an HBV carrier.
    Bonino F; Hoyer B; Ford E; Shih JW; Purcell RH; Gerin JL
    Hepatology; 1981; 1(2):127-31. PubMed ID: 6169614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liver cirrhosis associated with chronic hepatitis B virus infection in childhood.
    Bortolotti F; Calzia R; Cadrobbi P; Giacchini R; Ciravegna B; Armigliato M; Piscopo R; Realdi G
    J Pediatr; 1986 Feb; 108(2):224-7. PubMed ID: 3944707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Delta infection in HBsAg carriers].
    Hess G; Slusarczyk J; Hansson BG; Dienes HP; Baumann W; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1984 Dec; 22(12):692-6. PubMed ID: 6396986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and histological features of delta infection in chronic hepatitis B virus carriers.
    Lok AS; Lindsay I; Scheuer PJ; Thomas HC
    J Clin Pathol; 1985 May; 38(5):530-3. PubMed ID: 3998187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fulminant delta hepatitis in chronic asymptomatic HBsAg carriers.
    Tassopoulos N; Roumeliotou-Karayannis A; Nakopoulou L; Calafatas P; Papaevangelou G
    JAMA; 1985 Apr; 253(16):2362-3. PubMed ID: 3981762
    [No Abstract]   [Full Text] [Related]  

  • 30. Hepatic expression of hepatitis B and delta virus antigens in patients with acute and chronic hepatitis.
    Pilleri G; Faa G; Liguori C; Goffi C; Lai E
    Ric Clin Lab; 1985; 15(4):337-42. PubMed ID: 3914698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sex difference in chronic hepatitis B virus infection: an appraisal based on the status of hepatitis B e antigen and antibody.
    Chu CM; Liaw YF; Sheen IS; Lin DY; Huang MJ
    Hepatology; 1983; 3(6):947-50. PubMed ID: 6313507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The delta agent in acute and chronic hepatitis B infection in Sweden.
    Norkrans G; Hermodsson S; Iwarson S
    Scand J Gastroenterol; 1983 Jul; 18(5):675-8. PubMed ID: 6675189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Delta hepatitis in Switzerland. Determination of delta antigens and delta antibodies in 397 HBsAg-positive patients (1978-1984)].
    Burkhardt F; Schilt U
    Schweiz Med Wochenschr; 1984 Jul; 114(30):1042-6. PubMed ID: 6474132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequency and significance of delta antibody in acute and chronic hepatitis B. A United States experience.
    Shiels MT; Czaja AJ; Taswell HF; Gerin JL; Purcell RH; Ludwig J; Rakela J; Nelson CA
    Gastroenterology; 1985 Dec; 89(6):1230-4. PubMed ID: 4054516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute delta hepatitis without circulating HBsAg.
    De Cock KM; Govindarajan S; Redeker AG
    Gut; 1985 Feb; 26(2):212-4. PubMed ID: 3967840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term delta superinfection in hepatitis B surface antigen carriers and its relationship to the course of chronic hepatitis.
    Colombo M; Cambieri R; Rumi MG; Ronchi G; Del Ninno E; De Franchis R
    Gastroenterology; 1983 Aug; 85(2):235-9. PubMed ID: 6345255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver enzyme concentrations as measure of possible infectivity in chronic asymptomatic carriers of hepatitis B.
    Barbara JA; Mijovic V; Cleghorn TE; Tedder RS; Briggs M
    Br Med J; 1978 Dec; 2(6152):1600-2. PubMed ID: 728740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Delta agent infection: an unfavourable event in HBsAg positive chronic hepatitis.
    Sagnelli E; Piccinino F; Pasquale G; di Costanzo MG; Franzese R; Peinetti P
    Liver; 1984 Jun; 4(3):170-6. PubMed ID: 6748872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delta hepatitis in Malaysia.
    Sinniah M; Dimitrakakis M; Tan DS
    Southeast Asian J Trop Med Public Health; 1986 Jun; 17(2):229-33. PubMed ID: 3787309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natural history of acute hepatitis B surface antigen-positive hepatitis in Greek adults.
    Tassopoulos NC; Papaevangelou GJ; Sjogren MH; Roumeliotou-Karayannis A; Gerin JL; Purcell RH
    Gastroenterology; 1987 Jun; 92(6):1844-50. PubMed ID: 3569758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.